| 8/7/2026 | BlackRock Inc. | 1,944,236 | $16.92M | 0.0% | N/A | 5.142% | |
| 8/7/2026 | Deutsche Bank AG | 28,412 | $247K | 0.0% | N/A | 0.075% | |
| 8/7/2026 | Mitsubishi UFJ Asset Management Co. Ltd. | 110,557 | $962K | 0.0% | N/A | 0.292% | |
| 8/6/2026 | Bank of New York Mellon Corp | 72,758 | $633K | 0.0% | N/A | 0.192% | |
| 8/6/2026 | GSA Capital Partners LLP | 49,160 | $428K | 0.0% | N/A | 0.130% | |
| 5/16/2026 | First Light Asset Management LLC | 6,072,563 | $37.16M | 3.3% | +25.6% | 16.061% | |
| 5/15/2026 | Intelligence Driven Advisers LLC | 10,000 | $61K | 0.0% | N/A | 0.026% | |
| 5/15/2026 | Granahan Investment Management LLC | 695,070 | $4.25M | 0.2% | +662.6% | 1.838% | |
| 5/14/2026 | Renaissance Technologies LLC | 230,200 | $1.41M | 0.0% | +3.6% | 0.609% | |
| 5/14/2026 | Sei Investments Co. | 164,894 | $1.01M | 0.0% | +101.2% | 0.436% | |
Get the Latest News and Ratings for MASS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.
|
| 5/8/2026 | Amova Asset Management Americas Inc. | 269,873 | $1.65M | 0.0% | -6.3% | 0.721% | |
| 5/7/2026 | Dimensional Fund Advisors LP | 118,751 | $726K | 0.0% | -51.8% | 0.317% | |
| 5/5/2026 | Bank of New York Mellon Corp | 59,041 | $361K | 0.0% | -3.2% | 0.158% | |
| 4/30/2026 | Sumitomo Mitsui Trust Group Inc. | 269,873 | $1.65M | 0.0% | -6.3% | 0.722% | |
| 4/28/2026 | GM Advisory Group LLC | 238,218 | $1.46M | 0.1% | -14.6% | 0.637% | |
| 2/18/2026 | XTX Topco Ltd | 19,852 | $104K | 0.0% | -55.9% | 0.055% | |
| 2/18/2026 | Millennium Management LLC | 158,103 | $830K | 0.0% | +409.0% | 0.437% | |
| 2/18/2026 | Engineers Gate Manager LP | 26,681 | $140K | 0.0% | N/A | 0.074% | |
| 2/18/2026 | Bridgeway Capital Management LLC | 50,500 | $265K | 0.0% | +65.6% | 0.140% | |
| 2/17/2026 | First Light Asset Management LLC | 4,836,186 | $25.39M | 1.9% | +92.6% | 13.363% | |
| 2/17/2026 | State of Wisconsin Investment Board | 32,294 | $170K | 0.0% | N/A | 0.089% | |
| 2/17/2026 | Granahan Investment Management LLC | 91,141 | $478K | 0.0% | +41.7% | 0.252% | |
| 2/17/2026 | Graham Capital Management L.P. | 20,787 | $109K | 0.0% | +12.9% | 0.057% | |
| 2/17/2026 | Opal Capital LLC | 17,581 | $92K | 0.0% | N/A | 0.049% | |
| 2/17/2026 | Meros Investment Management LP | 347,035 | $1.82M | 0.7% | +232.7% | 0.959% | |
| 2/17/2026 | Needham Investment Management LLC | 770,000 | $4.04M | 0.3% | +246.8% | 2.128% | |
| 2/16/2026 | Squarepoint Ops LLC | 218,676 | $1.15M | 0.0% | +63.5% | 0.604% | |
| 2/16/2026 | Barclays PLC | 44,528 | $234K | 0.0% | +15.4% | 0.123% | |
| 2/13/2026 | Marshall Wace LLP | 190,635 | $1.00M | 0.0% | -56.6% | 0.527% | |
| 2/13/2026 | GM Advisory Group LLC | 278,792 | $1.46M | 0.1% | -58.9% | 0.770% | |
| 2/13/2026 | PCM Encore LLC | 11,830 | $62K | 0.0% | N/A | 0.033% | |
| 2/13/2026 | Essex Investment Management Co. LLC | 482,614 | $2.53M | 0.4% | -2.3% | 1.334% | |
| 2/13/2026 | State Street Corp | 596,294 | $3.13M | 0.0% | -74.1% | 1.648% | |
| 2/13/2026 | Wells Fargo & Company MN | 30,623 | $161K | 0.0% | +72.1% | 0.085% | |
| 2/12/2026 | Jane Street Group LLC | 36,795 | $193K | 0.0% | N/A | 0.102% | |
| 2/12/2026 | HRT Financial LP | 154,830 | $812K | 0.0% | N/A | 0.428% | |
| 2/12/2026 | Renaissance Technologies LLC | 222,100 | $1.17M | 0.0% | +6.1% | 0.614% | |
| 2/12/2026 | Dimensional Fund Advisors LP | 246,614 | $1.30M | 0.0% | -24.1% | 0.681% | |
| 2/12/2026 | IQ EQ FUND MANAGEMENT IRELAND Ltd | 78,026 | $410K | 0.0% | +47.8% | 0.216% | |
| 2/12/2026 | Campbell & CO Investment Adviser LLC | 80,553 | $423K | 0.0% | +21.2% | 0.223% | |
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad) A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for Phase 2 trials in progressive multiple sclerosis.
Unlike existing treatments that suppress the immune system, Lucid-MS is designed to protect myelin. In pre-clinical models, it led to movement recovery including walking.
Independent research projects peak annual sales up to 5 billion dollars, yet shares still trade under 5 dollars. Learn why this FDA milestone could be a turning point for investors |
| 2/11/2026 | ARK Investment Management LLC | 1,985,986 | $10.43M | 0.1% | +1.6% | 5.488% | |
| 2/11/2026 | Deutsche Bank AG | 18,429 | $97K | 0.0% | +3,351.1% | 0.051% | |
| 2/11/2026 | Amova Asset Management Americas Inc. | 288,081 | $1.51M | 0.0% | -9.5% | 0.796% | |
| 2/10/2026 | Goldman Sachs Group Inc. | 199,286 | $1.05M | 0.0% | +150.1% | 0.551% | |
| 2/10/2026 | AXQ Capital LP | 28,125 | $148K | 0.0% | +115.6% | 0.078% | |
| 2/10/2026 | Intech Investment Management LLC | 11,515 | $60K | 0.0% | -13.0% | 0.032% | |
| 2/9/2026 | Geode Capital Management LLC | 688,566 | $3.62M | 0.0% | +2.5% | 1.902% | |
| 2/6/2026 | Legato Capital Management LLC | 155,594 | $817K | 0.1% | +9.5% | 0.430% | |
| 2/6/2026 | Nano Cap New Millennium Growth Fund L P | 120,000 | $630K | 0.5% | N/A | 0.332% | |
| 2/6/2026 | Prescott Group Capital Management L.L.C. | 361,595 | $1.90M | 0.2% | +90.3% | 0.999% | |
| 2/5/2026 | HighMark Wealth Management LLC | 241,000 | $1.27M | 0.5% | N/A | 0.666% | |
| 2/4/2026 | First Eagle Investment Management LLC | 623,883 | $3.28M | 0.0% | +3.3% | 1.724% | |
| 2/4/2026 | 49 Wealth Management LLC | 17,581 | $92K | 0.0% | -8.4% | 0.049% | |
| 2/3/2026 | Mitsubishi UFJ Asset Management Co. Ltd. | 140,503 | $715K | 0.0% | -30.5% | 0.388% | |
| 2/2/2026 | Strs Ohio | 29,700 | $156K | 0.0% | +130.2% | 0.082% | |
| 1/29/2026 | Concurrent Investment Advisors LLC | 11,745 | $62K | 0.0% | -50.0% | 0.032% | |
| 1/23/2026 | Sumitomo Mitsui Trust Group Inc. | 288,081 | $1.51M | 0.0% | -9.5% | 0.796% | |
| 1/1/2026 | JPMorgan Chase & Co. | 11,238 | $98K | 0.0% | -15.2% | 0.031% | |
| 11/19/2025 | GM Advisory Group LLC | 678,086 | $5.94M | 0.3% | -41.8% | 1.874% | |
| 11/17/2025 | Susquehanna International Group LLP | 23,778 | $208K | 0.0% | -45.4% | 0.066% | |
| 11/17/2025 | Millennium Management LLC | 31,063 | $272K | 0.0% | -62.4% | 0.086% | |
| 11/17/2025 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 12,700 | $111K | 0.0% | -15.2% | 0.035% | |
| 11/17/2025 | Granahan Investment Management LLC | 64,338 | $564K | 0.0% | N/A | 0.178% | |
| 11/17/2025 | First Light Asset Management LLC | 2,510,496 | $21.99M | 2.1% | +135.2% | 6.937% | |
| 11/17/2025 | Brevan Howard Capital Management LP | 11,600 | $102K | 0.0% | N/A | 0.032% | |
| 11/17/2025 | Bank of America Corp DE | 270,069 | $2.37M | 0.0% | -25.6% | 0.746% | |
| 11/17/2025 | Alliancebernstein L.P. | 45,850 | $402K | 0.0% | -17.8% | 0.127% | |
| 11/14/2025 | Schonfeld Strategic Advisors LLC | 103,025 | $902K | 0.0% | -56.4% | 0.285% | |
| 11/14/2025 | Raymond James Financial Inc. | 183,282 | $1.61M | 0.0% | +2,649.5% | 0.506% | |
| 11/14/2025 | Brooklyn Investment Group | 65,631 | $575K | 0.0% | N/A | 0.181% | |
| 11/14/2025 | Squarepoint Ops LLC | 133,774 | $1.17M | 0.0% | N/A | 0.370% | |
| 11/13/2025 | BNP Paribas Financial Markets | 5,374 | $47K | 0.0% | -74.8% | 0.015% | |
| 11/13/2025 | FourThought Financial Partners LLC | 37,334 | $327K | 0.0% | N/A | 0.103% | |
| 11/13/2025 | Russell Investments Group Ltd. | 10,640 | $93K | 0.0% | N/A | 0.029% | |
| 11/12/2025 | Amova Asset Management Americas Inc. | 318,350 | $2.79M | 0.0% | -19.3% | 0.888% | |
| 11/12/2025 | ARK Investment Management LLC | 1,953,772 | $17.12M | 0.1% | -26.2% | 5.448% | |
| 11/12/2025 | Dimensional Fund Advisors LP | 324,788 | $2.84M | 0.0% | -10.5% | 0.906% | |
| 11/12/2025 | Cresset Asset Management LLC | 16,100 | $141K | 0.0% | +37.1% | 0.045% | |
| 11/12/2025 | First Eagle Investment Management LLC | 603,962 | $5.29M | 0.0% | +125.9% | 1.684% | |
| 11/12/2025 | Mitsubishi UFJ Asset Management Co. Ltd. | 202,175 | $1.77M | 0.0% | -4.9% | 0.564% | |
| 11/12/2025 | Intech Investment Management LLC | 13,236 | $116K | 0.0% | -23.0% | 0.037% | |
| 11/10/2025 | AXQ Capital LP | 13,045 | $114K | 0.0% | N/A | 0.036% | |
| 11/7/2025 | Cassaday & Co Wealth Management LLC | 71,629 | $627K | 0.0% | N/A | 0.200% | |
| 11/7/2025 | Vanguard Group Inc. | 1,421,732 | $12.45M | 0.0% | -0.7% | 3.965% | |
| 11/7/2025 | JPMorgan Chase & Co. | 11,238 | $98K | 0.0% | -15.2% | 0.031% | |
| 11/6/2025 | Essex Investment Management Co. LLC | 493,949 | $4.33M | 0.7% | +3.5% | 1.377% | |
| 11/5/2025 | IQ EQ FUND MANAGEMENT IRELAND Ltd | 52,787 | $462K | 0.0% | +38.2% | 0.147% | |
| 10/30/2025 | Strs Ohio | 12,900 | $113K | 0.0% | N/A | 0.036% | |
| 10/28/2025 | Campbell & CO Investment Adviser LLC | 66,481 | $582K | 0.0% | -38.8% | 0.185% | |
| 10/27/2025 | Sumitomo Mitsui Trust Group Inc. | 318,350 | $2.79M | 0.0% | -20.1% | 0.888% | |
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad) A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for Phase 2 trials in progressive multiple sclerosis.
Unlike existing treatments that suppress the immune system, Lucid-MS is designed to protect myelin. In pre-clinical models, it led to movement recovery including walking.
Independent research projects peak annual sales up to 5 billion dollars, yet shares still trade under 5 dollars. Learn why this FDA milestone could be a turning point for investors |
| 10/23/2025 | SG Americas Securities LLC | 17,651 | $155K | 0.0% | -26.0% | 0.049% | |
| 10/14/2025 | Farther Finance Advisors LLC | 3,233 | $28K | 0.0% | N/A | 0.009% | |
| 10/6/2025 | Old Port Advisors | 38,629 | $338K | 0.1% | -47.5% | 0.108% | |
| 8/16/2025 | Nikko Asset Management Americas Inc. | 394,375 | $2.81M | 0.0% | -4.4% | 1.100% | |
| 8/15/2025 | Manatuck Hill Partners LLC | 80,000 | $570K | 0.2% | N/A | 0.223% | |
| 8/15/2025 | BNP Paribas Financial Markets | 21,290 | $152K | 0.0% | -12.1% | 0.059% | |
| 8/15/2025 | Bank of America Corp DE | 363,217 | $2.59M | 0.0% | +221.7% | 1.013% | |
| 8/14/2025 | First Light Asset Management LLC | 1,067,613 | $7.61M | 1.0% | -37.2% | 2.977% | |
| 8/14/2025 | Jane Street Group LLC | 47,850 | $341K | 0.0% | N/A | 0.133% | |
| 8/14/2025 | Raymond James Financial Inc. | 6,666 | $48K | 0.0% | N/A | 0.019% | |